{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:18:50Z","timestamp":1794028730492,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","award":["6210100362"],"award-info":[{"award-number":["6210100362"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["OGI-126"],"award-info":[{"award-number":["OGI-126"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["OGI-126"],"award-info":[{"award-number":["OGI-126"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["OGI-126"],"award-info":[{"award-number":["OGI-126"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["OGI-126"],"award-info":[{"award-number":["OGI-126"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["oapplication # 12502"],"award-info":[{"award-number":["oapplication # 12502"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["oapplication # 12502"],"award-info":[{"award-number":["oapplication # 12502"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13148-019-0708-z","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T09:02:38Z","timestamp":1565686958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["DNA methylation signature is prognostic of choroid plexus tumor aggressiveness"],"prefix":"10.1186","volume":"11","author":[{"given":"Malgorzata","family":"Pienkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaa","family":"Choufani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei L.","family":"Turinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Novokmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brudno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Weksberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Shlien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Tabori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Jabado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Capper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hasselblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-9763","authenticated-orcid":false,"given":"David","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"2","key":"708_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97\u2013109.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"708_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/1097-0029(20010101)52:1<104::AID-JEMT12>3.0.CO;2-3","volume":"52","author":"CH Rickert","year":"2001","unstructured":"Rickert CH, Paulus W. Tumors of the choroid plexus. Microsc Res Tech. 2001;52(1):104\u201311.","journal-title":"Microsc Res Tech"},{"issue":"3","key":"708_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/00006123-199803000-00006","volume":"42","author":"C Berger","year":"1998","unstructured":"Berger C, Thiesse P, Lellouch-Tubiana A, Kalifa C, Pierre-Kahn A, Bouffet E. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery. 1998;42(3):470\u20135.","journal-title":"Neurosurgery"},{"issue":"2","key":"708_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1015773624733","volume":"57","author":"LK Fitzpatrick","year":"2002","unstructured":"Fitzpatrick LK, Aronson LJ. Cohen KJ. Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected? J Neurooncol. 2002;57(2):123\u20136.","journal-title":"J Neurooncol"},{"issue":"3","key":"708_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11060-007-9428-x","volume":"85","author":"B Wrede","year":"2007","unstructured":"Wrede B, Liu P, Wolff JE. Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol. 2007;85(3):345\u201351.","journal-title":"J Neurooncol"},{"issue":"9170","key":"708_CR6","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(99)01744-4","volume":"353","author":"JE Wolff","year":"1999","unstructured":"Wolff JE, Sajedi M, Coppes MJ, Anderson RA, Egeler RM. Radiation therapy and survival in choroid plexus carcinoma. Lancet. 1999;353(9170):2126.","journal-title":"Lancet"},{"issue":"12","key":"708_CR7","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1200\/JCO.2009.26.8169","volume":"28","author":"U Tabori","year":"2010","unstructured":"Tabori U, Shlien A, Baskin B, Levitt S, Ray P, Alon N, et al. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol. 2010;28(12):1995\u20132001.","journal-title":"J Clin Oncol"},{"issue":"21","key":"708_CR8","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard G, Renaux-Petel M, Flaman JM, Charbonnier C, Fermey P, Belotti M, et al. Revisiting Li-Fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345\u201352.","journal-title":"J Clin Oncol"},{"issue":"1","key":"708_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/1078-0432.CCR-14-1324","volume":"21","author":"DM Merino","year":"2015","unstructured":"Merino DM, Shlien A, Villani A, Pienkowska M, Mack S, Ramaswamy V, et al. Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups. Clin Cancer Res. 2015;21(1):184\u201392.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"708_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","volume":"18","author":"EC Schwalbe","year":"2017","unstructured":"Schwalbe EC, Lindsey JC, Nakjang S, Crosier S, Smith AJ, Hicks D, et al. Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study. Lancet Oncol. 2017;18(7):958\u201371.","journal-title":"Lancet Oncol"},{"issue":"2","key":"708_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5808\/GI.2016.14.2.46","volume":"14","author":"W Choi","year":"2016","unstructured":"Choi W, Lee J, Lee JY, Lee SM, Kim DW, Kim YJ. Classification of colon cancer patients based on the methylation patterns of promoters. Genomics Inform. 2016;14(2):46\u201352.","journal-title":"Genomics Inform"},{"issue":"7697","key":"708_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u201374.","journal-title":"Nature"},{"issue":"6","key":"708_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nov322","volume":"18","author":"C Thomas","year":"2016","unstructured":"Thomas C, Sill M, Ruland V, Witten A, Hartung S, Kordes U, et al. Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups. Neuro Oncol. 2016;18(6):790\u20136.","journal-title":"Neuro Oncol"},{"issue":"2","key":"708_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8(2):203\u20139.","journal-title":"Epigenetics"},{"issue":"11","key":"708_CR15","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.arthro.2008.09.015","volume":"24","author":"MA Kuhn","year":"2008","unstructured":"Kuhn MA, Olexa T, Dhawan A. Building predictive models in R Using the caret package. Arthroscopy. 2008;24(11):1299\u2013300.","journal-title":"Arthroscopy"},{"issue":"3","key":"708_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1101\/gr.111922.110","volume":"21","author":"S Choufani","year":"2011","unstructured":"Choufani S, Shapiro JS, Susiarjo M, Butcher DT, Grafodatskaya D, Lou Y, et al. A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes. Genome Res. 2011;21(3):465\u201376.","journal-title":"Genome Res"},{"issue":"5","key":"708_CR17","first-page":"485","volume":"57","author":"K Szczaurska","year":"2003","unstructured":"Szczaurska K, Mazurkiewicz M, Opolski A. The role of GABA-ergic system in carcinogenesis. Postepy Hig Med Dosw. 2003;57(5):485\u2013500.","journal-title":"Postepy Hig Med Dosw"},{"issue":"10","key":"708_CR18","first-page":"1135","volume":"21","author":"M Watanabe","year":"2006","unstructured":"Watanabe M, Maemura K, Oki K, Shiraishi N, Shibayama Y, Katsu K. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. Histol Histopathol. 2006;21(10):1135\u201341.","journal-title":"Histol Histopathol"},{"issue":"10","key":"708_CR19","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/carcin\/bgn041","volume":"29","author":"HM Schuller","year":"2008","unstructured":"Schuller HM, Al-Wadei HA, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis. 2008;29(10):1979\u201385.","journal-title":"Carcinogenesis"},{"issue":"8","key":"708_CR20","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1080\/02841860801961265","volume":"47","author":"M Abdul","year":"2008","unstructured":"Abdul M, McCray SD, Hoosein NM. Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer. Acta Oncol. 2008;47(8):1546\u201350.","journal-title":"Acta Oncol"},{"key":"708_CR21","first-page":"171","volume":"24","author":"SZ Young","year":"2009","unstructured":"Young SZ, Bordey A. GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology (Bethesda). 2009;24:171\u201385.","journal-title":"Physiology (Bethesda)"},{"issue":"7","key":"708_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.4161\/cbt.4.7.1827","volume":"4","author":"PH Thaker","year":"2005","unstructured":"Thaker PH, Yokoi K, Jennings NB, Li Y, Rebhun RB, Rousseau DL Jr, et al. Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal. Cancer Biol Ther. 2005;4(7):753\u20138.","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"708_CR23","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.neuron.2013.08.022","volume":"80","author":"JA Evans","year":"2013","unstructured":"Evans JA, Leise TL, Castanon-Cervantes O, Davidson AJ. Dynamic interactions mediated by nonredundant signaling mechanisms couple circadian clock neurons. Neuron. 2013;80(4):973\u201383.","journal-title":"Neuron"},{"issue":"3","key":"708_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00429-014-0720-1","volume":"220","author":"T Quintela","year":"2015","unstructured":"Quintela T, Sousa C, Patriarca FM, Goncalves I, Santos CR. Gender associated circadian oscillations of the clock genes in rat choroid plexus. Brain Struct Funct. 2015;220(3):1251\u201362.","journal-title":"Brain Struct Funct"},{"issue":"2","key":"708_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuron.2012.04.006","volume":"74","author":"U Albrecht","year":"2012","unstructured":"Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron. 2012;74(2):246\u201360.","journal-title":"Neuron"},{"issue":"2","key":"708_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/01.ede.0000152525.21924.54","volume":"16","author":"RG Stevens","year":"2005","unstructured":"Stevens RG. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology. 2005;16(2):254\u20138.","journal-title":"Epidemiology"},{"issue":"5","key":"708_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2008.08.022","volume":"134","author":"CB Green","year":"2008","unstructured":"Green CB, Takahashi JS, Bass J. The meter of metabolism. Cell. 2008;134(5):728\u201342.","journal-title":"Cell"},{"issue":"1","key":"708_CR28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00001648-200101000-00013","volume":"12","author":"J Hansen","year":"2001","unstructured":"Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12(1):74\u20137.","journal-title":"Epidemiology"},{"issue":"13","key":"708_CR29","doi-asserted-by":"publisher","first-page":"7623","DOI":"10.1073\/pnas.121038198","volume":"98","author":"AJ Carrasco","year":"2001","unstructured":"Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci U S A. 2001;98(13):7623\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"708_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1152\/japplphysiol.00885.2005","volume":"100","author":"CR Hancock","year":"2006","unstructured":"Hancock CR, Janssen E, Terjung RL. Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice. J Appl Physiol (1985). 2006;100(2):406\u201313.","journal-title":"J Appl Physiol (1985)"},{"key":"708_CR31","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1038\/emm.2013.65","volume":"45","author":"Y Lee","year":"2013","unstructured":"Lee Y, Kim EK. AMP-activated protein kinase as a key molecular link between metabolism and clockwork. Exp Mol Med. 2013;45:e33.","journal-title":"Exp Mol Med"},{"issue":"7","key":"708_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/carcin\/bgi075","volume":"26","author":"ST Chen","year":"2005","unstructured":"Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005;26(7):1241\u20136.","journal-title":"Carcinogenesis"},{"issue":"1","key":"708_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13277-011-0258-2","volume":"33","author":"CM Hsu","year":"2012","unstructured":"Hsu CM, Lin SF, Lu CT, Lin PM, Yang MY. Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumour Biol. 2012;33(1):149\u201355.","journal-title":"Tumour Biol"},{"issue":"3","key":"708_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopha.2011.11.007","volume":"66","author":"G Mazzoccoli","year":"2012","unstructured":"Mazzoccoli G, Piepoli A, Carella M, Panza A, Pazienza V, Benegiamo G, et al. Altered expression of the clock gene machinery in kidney cancer patients. Biomed Pharmacother. 2012;66(3):175\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"708_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s11605-012-2112-2","volume":"17","author":"D Relles","year":"2013","unstructured":"Relles D, Sendecki J, Chipitsyna G, Hyslop T, Yeo CJ, Arafat HA. Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg. 2013;17(3):443\u201350.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"708_CR36","first-page":"619","volume":"7","author":"H Zhao","year":"2014","unstructured":"Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu XY, et al. Prognostic relevance of period1 (Per1) and period2 (Per2) expression in human gastric cancer. Int J Clin Exp Pathol. 2014;7(2):619\u201330.","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"708_CR37","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3109\/07420520903431301","volume":"26","author":"X Yang","year":"2009","unstructured":"Yang X, Wood PA, Ansell CM, Quiton DF, Oh EY, Du-Quiton J, et al. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int. 2009;26(7):1323\u201339.","journal-title":"Chronobiol Int"},{"issue":"4","key":"708_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2443.2010.01384.x","volume":"15","author":"K Miyazaki","year":"2010","unstructured":"Miyazaki K, Wakabayashi M, Hara Y, Ishida N. Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells. 2010;15(4):351\u20138.","journal-title":"Genes Cells"},{"issue":"1","key":"708_CR39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.gde.2012.02.008","volume":"22","author":"J Sandoval","year":"2012","unstructured":"Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev. 2012;22(1):50\u20135.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"708_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10549-004-6603-z","volume":"91","author":"S You","year":"2005","unstructured":"You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res Treat. 2005;91(1):47\u201360.","journal-title":"Breast Cancer Res Treat."}],"updated-by":[{"DOI":"10.1186\/s13148-019-0737-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000}}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-019-0708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-019-0708-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-019-0708-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T19:06:10Z","timestamp":1597172770000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-019-0708-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s13148-019-0708-z","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"After publication of the original article [1], authors have requested to add a \u2018J\u2019 as middle name for Richard Gilbertson. Hence, full name should be Richard J Gilbertson.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained for the study from the Institutional Research Ethics Board. Informed consent was obtained from the parents\/legal guardians of all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}